Sutro Biopharma Inc. (NASDAQ: STRO)
$4.33
+0.1050 ( +2.49% ) 489.5K
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Market Data
Open
$4.33
Previous close
$4.22
Volume
489.5K
Market cap
$353.76M
Day range
$4.00 - $4.33
52 week range
$2.01 - $6.13
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 10, 2024 |
10-q | Quarterly Reports | 72 | May 13, 2024 |
8-k | 8K-related | 13 | May 13, 2024 |
4 | Insider transactions | 1 | May 03, 2024 |
def | Proxies and info statements | 16 | Apr 26, 2024 |
ars | Annual reports | 1 | Apr 26, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
8-k | 8K-related | 14 | Apr 02, 2024 |
8-k | 8K-related | 15 | Apr 02, 2024 |
10-k | Annual reports | 103 | Mar 25, 2024 |